D. Wong

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, Y. Cormier, G. Goss, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, M. Moore, D. Stewart, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study

A. Scott, N. Lenzo, B. Chatterton, 2009, European Journal of Nuclear Medicine and Molecular Imaging.